Skip to main content

Advertisement

SpringerLink
Log in

Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers ofBRCA1 orBRCA2 mutations

  • Editorial
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Roukos DH, Kappas AM, Tsianos E. Role of surgery in the prophylaxis of hereditary cancer syndromes (editorial).Ann Surg Oncol 2002;9:607–9.

    Article  PubMed  Google Scholar 

  2. Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer.N Engl J Med 2001;344:539–48.

    Article  PubMed  CAS  Google Scholar 

  3. van’t Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer.Nature 2002; 415:530–6.

    Article  Google Scholar 

  4. Jazaeri A, Yee C, Sotiriou C, Brantley K, Boyd J, Liu E. Gene expression profiles of BRCA1-linked, and sporadic ovarian cancers?J Natl Cancer Inst 2002;94:990–1000.

    PubMed  CAS  Google Scholar 

  5. Hedenfalk I. Gene expression profiling of hereditary and sporadic ovarian cancers reveals unique BRCA1 and BRCA2 signatures.J Natl Cancer Inst 2002;94:960–1.

    PubMed  Google Scholar 

  6. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.Am J Hum Genet 1995;56:265–71.

    PubMed  CAS  Google Scholar 

  7. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families.Am J Hum Genet 1998;62:676–89.

    Article  PubMed  CAS  Google Scholar 

  8. Warner E, Foulkes W, Goodwin P, et al. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.J Natl Cancer Inst 1999;91:1241–7.

    Article  PubMed  CAS  Google Scholar 

  9. Hopper JL, Southey MC, Dite GS et al. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.Cancer Epidemiol Biomarkers Prev 1999;8:741–7.

    PubMed  CAS  Google Scholar 

  10. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.N Engl J Med 1997;336:1401–8.

    Article  PubMed  CAS  Google Scholar 

  11. Satagopan JM, Offit K, Foulkes W, et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Cancer Epidemiol Biomarkers Prev 2001;10:467–73.

    PubMed  CAS  Google Scholar 

  12. Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.Am J Hum Genet 2001;68:700–10.

    Article  PubMed  CAS  Google Scholar 

  13. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases.Br J Cancer 2000;83:1301–8.

    Article  Google Scholar 

  14. Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.J Natl Cancer Inst 2002; 94:1365–72.

    PubMed  CAS  Google Scholar 

  15. Thorlacius S, Struewing JP, Hartge P, et al. Population-based study of risk of breast cancer in carriers of BRCA2 mutation.Lancet 1998;352:1337–9.

    Article  PubMed  CAS  Google Scholar 

  16. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.N Engl J Med 1999;340:77–84.

    Article  PubMed  CAS  Google Scholar 

  17. Meijers-Heijboer H, van Geel B, van Putten WL et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.N Engl J Med 2001;345:159–64.

    Article  PubMed  CAS  Google Scholar 

  18. Schrag D, Kuntz KM, Garber JE, Weeks JC. Decision analysis—effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 and BRCA2 mutations.N Engl J Med 1997;336:1465–71. [Erratum,N Engl J Med 1997; 337:434].

    Article  PubMed  CAS  Google Scholar 

  19. Grann VR, Panageas KS, Whang W, Antman KH, Neugut AI. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.J Clin Oncol 1998;16:979–85.

    PubMed  CAS  Google Scholar 

  20. Rebbeck TR, Levin AM, Eisen A, et al. Breast cancer risk afer bilateral prophylactic oophorectomy in BRCA1 mutation carriers.J Natl Cancer Inst 1999;91:1475–9.

    Article  PubMed  CAS  Google Scholar 

  21. Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.N Engl J Med 2002;346:1616–22.

    Article  PubMed  Google Scholar 

  22. Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.N Engl J Med 2002;346:1609–15.

    Article  PubMed  Google Scholar 

  23. Gabriel SE, Woods JE, O’Fallon WM, Beard CM, Kurland LT, Melton LJ III. Complications leading to surgery after breast implantation.N Engl J Med 1997;336:677–82.

    Article  PubMed  CAS  Google Scholar 

  24. Frost MH, Schaid DJ, Sellers TA, et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy.JAMA 2000;284:319–24.

    Article  PubMed  CAS  Google Scholar 

  25. Fry A, Busby-Earle C, Rush R, Cull A. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer.Psychooncology 2001;10:231–41.

    Article  PubMed  CAS  Google Scholar 

  26. Kuhl CK, Schmutzler RK, Leutner C, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.Radiology 2000;215:267–79.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery (DHR, AMK), Medical School of University of Ioannina, 451 10, Ioannina, Greece

    Dimitrios H. Roukos MD & Angelos M. Kappas MD

  2. Department of Obstetrics and Gynecology (IG, DP), Medical School of University of Ioannina, 451 10, Ioannina, Greece

    Niki J. Agnanti MD & Evangelos Paraskevaidis MD

Authors
  1. Dimitrios H. Roukos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Niki J. Agnanti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Evangelos Paraskevaidis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Angelos M. Kappas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dimitrios H. Roukos MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roukos, D.H., Agnanti, N.J., Paraskevaidis, E. et al. Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers ofBRCA1 orBRCA2 mutations. Annals of Surgical Oncology 9, 941–943 (2002). https://doi.org/10.1007/BF02574510

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02574510

Search

Navigation